Zemplar

Paricalcitol is a vitamin D analog prescribed for managing secondary hyperparathyroidism in chronic kidney disease. It supports calcium balance and bone health. This oral medication is used under medical supervision. Always follow healthcare provider instructions.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease. It helps regulate parathyroid hormone levels, calcium, and phosphorus. The medication is often prescribed when kidney function declines. It may also be used in dialysis patients to support bone health.

Paricalcitol works by mimicking the action of vitamin D in the body, helping to reduce elevated parathyroid hormone levels. Patients may experience improved calcium absorption and balanced phosphorus levels over time. Some individuals notice better energy levels and reduced bone discomfort with regular use. Effects vary by individual and condition.

Paricalcitol should be taken exactly as directed by a healthcare provider to avoid complications. Regular blood tests are recommended to monitor calcium, phosphorus, and parathyroid hormone levels. Inform your doctor about any history of bone disorders or high calcium levels. Keep this medication out of reach of children and store it at room temperature.

Certain medications, including strong CYP3A4 inhibitors like ketoconazole, may affect how paricalcitol works. Avoid taking vitamin D supplements or calcium-based products without consulting a healthcare provider. Grapefruit juice may interact with paricalcitol, so discuss dietary habits with your doctor. Always review your current medications with a healthcare professional before starting paricalcitol.